Results 1 to 10 of about 36,486 (260)

Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery [PDF]

Annals of Surgery Open
Objective:. We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events ...
Alicia H. Li, MD, Yongmei Huang, MD, DrPH, Silvia S. Martins, MD, PhD, Yukio Suzuki, MD, PhD, Jennifer S. Ferris, PhD, Xiao Xu, PhD, Dawn L. Hershman, MD, Jason D. Wright, MD   +7 more
doaj   +4 more sources

“Now that we’ve opened the door”: challenges recovery home directors face when housing residents receiving medication for opioid use disorder [PDF]

Substance Abuse Treatment, Prevention, and Policy
Medications for opioid use disorder (MOUDs) are a well-established treatment strategy. Supported by evidence of their effectiveness to reduce opioid misuse, they promote stabilization, prevent overdose deaths, and promote long-term recovery ...
Jodie M. Dewey, Justin S. Bell, Juleigh Nowinski Konchak, Keiki Hinami, Dennis P. Watson   +4 more
doaj   +2 more sources

Induction of Medication for Opioid Use Disorder in Primary Care. [PDF]

J Am Board Fam Med
Overdoses and deaths from synthetic opioids grew sharply in the past decade. Most people with opioid use disorder (OUD) do not receive recommended evidence-based treatment: nationally, 72% to 87% of people who need OUD treatment do not receive medication for opioid use disorder (MOUD). Little is known about practice teams' experiences with home, office,
Hall TL, Fernald DH, Jiang V, Curcija K, LeMaster JW, Westfall JM, Nease DE, Zittleman L.   +7 more
europepmc   +4 more sources

Factors contributing to the expansion of medication for opioid use disorder (MOUD) within the New Hampshire Department of Corrections (NHDOC) [PDF]

Health & Justice
Introduction Expanding access to medication for opioid use disorder (MOUD) to people involved in the carceral system is a priority for the New Hampshire Department of Corrections (NHDOC), where more than 40% of residents have an opioid use disorder (OUD).
Nancy Clayman, Pracha Eamranond, Helen Hanks, Michael Mitcheff, Lisa RappaMannion, Diane York, Paula Mattis, Heidi Guinen, Alex Carp, Laura Olson, Kathleen Bell, Lydia Shahi, Elizabeth Saunders, Joshua Lee, Lisa Marsch   +14 more
doaj   +2 more sources

Prevalence and predictors of medication for opioid use disorder among reproductive-aged women [PDF]

Drug and Alcohol Dependence Reports
Background: Women of reproductive age would benefit from treatment of opioid use disorder (OUD) prior to pregnancy to improve maternal and infant outcomes.
Jennifer K. Bello, Nathaniel A. Dell, Aaron M. Laxton, Mary Conte, Lynn Chen   +4 more
doaj   +2 more sources

Starting a Prehospital Medication for Opioid Use Disorder Program. [PDF]

Prehosp Disaster Med
AbstractBackground:Over 2.7 million people have an opioid use disorder (OUD). Opioid-related deaths have steadily increased over the last decade. Although emergency department (ED)-based medication for OUD (MOUD) has been successful in initiating treatment for patients, there still is a need for improved access.
Seaberg DC, McKinnon J, Haselton L, Gallo D, Kolb J, Moran M, Vellanki S, Raubenolt A, Simon E, Jouriles N.   +9 more
europepmc   +3 more sources

Medication Treatment of Opioid Use Disorder [PDF]

Biological Psychiatry, 2020
Opioid use disorder (OUD) is a chronic, relapsing condition, often associated with legal, interpersonal, and employment problems. Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist).
James Bell, John Strang
openaire   +5 more sources

Medications Development for Treatment of Opioid Use Disorder [PDF]

Cold Spring Harbor Perspectives in Medicine, 2020
This review describes methods for preclinical evaluation of candidate medications to treat opioid use disorder (OUD). The review is founded on the propositions that (1) drug self-administration procedures provide the most direct method for assessment of medication effectiveness, (2) procedures that assess choice between opioid and nondrug reinforcers ...
E. Andrew Townsend, S. Stevens Negus, Matthew L. Banks   +2 more
openaire   +2 more sources

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder

Drug and Alcohol Dependence Reports, 2022
Background: Patients with opioid use disorder (OUD) have high hospital admission rates. Hospitalists, clinicians that work in inpatient medical settings, may have a unique opportunity to intervene on behalf of these patients, yet their experience with ...
Megan K Reed, Vignesh Murali, Nazanin Sarpoulaki, Jillian H. Zavodnick, Jeffrey K. Hom, Kristin L Rising   +5 more
doaj   +1 more source

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV

Drug and Alcohol Dependence Reports, 2023
Background: In the United States, a disproportionate number of persons with HIV (PWH) and opioid use disorder (OUD) are involved in the justice system. Medications for OUD (MOUD) can reduce convictions and incarceration time in persons with OUD. Extended-
Kaley Parchinski, Angela Di Paola, Allison P. Wilson, Sandra A. Springer   +3 more
doaj   +1 more source